<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02481232</url>
  </required_header>
  <id_info>
    <org_study_id>MCV4-001</org_study_id>
    <nct_id>NCT02481232</nct_id>
  </id_info>
  <brief_title>A Single-center, Open Trials to Evaluate the Safety of Freeze-dried Group ACYW135 Meningococcal Conjugate Vaccine</brief_title>
  <official_title>A Single-center, Open Trials to Evaluate the Safety of Freeze-dried Group ACYW135 Meningococcal Conjugate Vaccine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lanzhou Institute of Biological Products Co., Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Air Force Military Medical University, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Lanzhou Institute of Biological Products Co., Ltd</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Safety Evaluation of freeze-dried Group ACYW135 Meningococcal conjugate vaccine in healthy&#xD;
      people above 2-months-old&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There are five different age groups(18~55 years/7~17 years/1~6 years/7~10 months/2&#xD;
      months),each group has 40 people and divided into two subgroups. Each subgroup will inject&#xD;
      different vaccine(MCV4 4μg,MCV4 8μg).For 7~10 months&amp;2 months age groups,there are 2&amp;3&#xD;
      injection seperately. Each injection interval is 1 months.&#xD;
&#xD;
      After 7 days observation of 1 dose immunization in Group 18-55 years old adults, if there are&#xD;
      no serious adverse events associated with vaccines, or severe adverse reactions rate is less&#xD;
      than 10%, 7 to 17 years old and 1 to 6 years old age groups will continue to inoculate in&#xD;
      order. After the first dose of 7~10 months group and evaluating safety, 2 months group&#xD;
      immunized the first dose. All participants completed the immune procedure, then observed the&#xD;
      safety to 30 days after whole immunization.&#xD;
&#xD;
      Data collection: Subjects completed diary card, the researchers collected original data and&#xD;
      fill out the case report form for data entry and statistical analysis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">April 2016</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>systemic and local reactions 30 days after full-course vaccination</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Meningococcal Meningitis</condition>
  <arm_group>
    <arm_group_label>freeze-dried group ACYW135 MCV 4μg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4μg group: vaccines serial number is A0001-A0100（18-55 years-old group A0001-A0020，7-17 years-old group A0021-A0040，1-6 years-old group A0041-A0060，7-10 months-old group A0061-A0080，2 months-old group A0081-A0100）</description>
  </arm_group>
  <arm_group>
    <arm_group_label>freeze-dried group ACYW135 MCV 8μg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>8μg group: vaccines serial number is B0001-B0100（18-55 years-old group B0001-B0020，7-17 years-old group B0021-B0040，1-6 years-old group B0041-B0060，7-10 months-old group B0061-B0080，2 months-old group B0081-B0100）</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>freeze-dried group ACYW135 MCV</intervention_name>
    <description>Group A, C, Y and W135 Meningococcal conjugate vaccine is suitable for immune prevention of epidemic cerebrospinal meningitis more than 2 months of age population</description>
    <arm_group_label>freeze-dried group ACYW135 MCV 4μg</arm_group_label>
    <arm_group_label>freeze-dried group ACYW135 MCV 8μg</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy infants unimmunized Group A&amp;C meningococcal conjugate vaccine or Group A&#xD;
             meningococcal polysaccharide vaccine which is above 2~11 months-old, and healthy&#xD;
             toddler more than 1-year-old without booster immunization.&#xD;
&#xD;
          -  The guardian or himself informed consent, and signed the informed consent form;&#xD;
&#xD;
          -  The guardian and family agreed to abide by the requirements of clinical trial scheme;&#xD;
&#xD;
          -  Participants has no history of immunoglobulin vaccination in the last 2 months / 2&#xD;
             months-old infants has no history of immunoglobulin vaccination after born, there is&#xD;
             no history of other live vaccine inoculation before vaccination in 14 days, within 7&#xD;
             days without other inactivated vaccine immunization history;&#xD;
&#xD;
          -  the axillary temperature &lt; 37.1 ℃;&#xD;
&#xD;
          -  2-months-old group in the age of 61-90 days;&#xD;
&#xD;
          -  7-months-old group in the age of 211-300 days;&#xD;
&#xD;
          -  1-year-old group in age of one full year of life.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Have allergies, convulsions, seizures, encephalopathy and psychiatric history or&#xD;
             family history;&#xD;
&#xD;
          -  Neomycin, streptomycin and polymyxin B allergies;&#xD;
&#xD;
          -  With immunodeficiency, immunosuppressant therapy;&#xD;
&#xD;
          -  History of meningitis;&#xD;
&#xD;
          -  Women in lactation or pregnant;&#xD;
&#xD;
          -  Acute febrile diseases and infectious diseases;&#xD;
&#xD;
          -  History of labor abnormalities, choking rescue, congenital malformations,&#xD;
             developmental disorders or serious chronic disease patients;&#xD;
&#xD;
          -  Had a severe allergic reaction of vaccination in the past;&#xD;
&#xD;
          -  Took oral steroids more than 14 days in last month;&#xD;
&#xD;
          -  Had high fever (axillary temperature≥38.0℃ or higher)in the past three days;&#xD;
&#xD;
          -  Prepare to attend or is in any other drug clinical study;&#xD;
&#xD;
          -  Meningococcal vaccine contraindications and any situation which researchers think that&#xD;
             may affect test evaluation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Months</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Zhiqiang Zhao, Manager</last_name>
    <phone>008613919133537</phone>
    <email>matinzhao@sina.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hubei CDC</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430079</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Faxian Zhan, Manager</last_name>
      <phone>008613908639947</phone>
      <email>zhanfx@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <study_first_submitted>June 23, 2015</study_first_submitted>
  <study_first_submitted_qc>June 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 25, 2015</study_first_posted>
  <last_update_submitted>June 23, 2015</last_update_submitted>
  <last_update_submitted_qc>June 23, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 25, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Meningitis, Meningococcal</mesh_term>
    <mesh_term>Meningitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

